Altered Busulphan Exposure Associated with Concomitant Omeprazole during Hematopoietic Stem Cell Transplantation Conditioning: A Two-Case Report
Clinical Drug Investigation · 2026-09 · 46 (9) · 1031-1036
DOI: 10.1007/s40261-026-01581-9 ↗Kurz gefasst
Fallbericht in der Zeitschrift Clinical Drug Investigation, online erschienen am 10.07.2026. Verfasst von Ibrahim El-Serafi und 4 weiteren Autor:innen. Beteiligte Einrichtung: Experimental Cancer Medicine (ECM), Department of Laboratory Medicine, Karolinska Institutet-Huddinge, 141 86, NovumStockholm, Sweden. Hauptthemen laut MEDLINE: Omeprazole, Hematopoietic Stem Cell Transplantation, Busulfan, Transplantation Conditioning. Die Arbeit nennt 17 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Karolinska Institute.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Experimental Cancer Medicine (ECM), Department of Laboratory Medicine, Karolinska Institutet-Huddinge, 141 86, NovumStockholm, Sweden.
- Basic Medical Sciences Department, College of Medicine, Ajman University, Ajman, UAE.
- Department of Human Resource, The First Affiliated Hospital of Chongqing Medical University, Chongqing, 400010, China.
- Clinical Research Center and Center of Allogeneic Stem Cell Transplantation (CAST), Karolinska University Hospital Huddinge, Huddinge, Sweden.
- Gloria and Seymour Epstein Chair in Cell Therapy and Transplantation, Princess Margaret Cancer Centre and University of Toronto, Toronto, Canada.
- Princess Margaret Cancer Centre, University Health Network, Toronto, Canada.
Förderung
- Karolinska Institute
Zitieren
APA
El-Serafi, I., He, R., Zhao, Y., Mattsson, J., & Hassan, M. (2026). Altered Busulphan Exposure Associated with Concomitant Omeprazole during Hematopoietic Stem Cell Transplantation Conditioning: A Two-Case Report. Clinical Drug Investigation, 46(9), 1031-1036. https://doi.org/10.1007/s40261-026-01581-9
Vancouver
El-Serafi I, He R, Zhao Y, Mattsson J, Hassan M. Altered Busulphan Exposure Associated with Concomitant Omeprazole during Hematopoietic Stem Cell Transplantation Conditioning: A Two-Case Report. Clinical Drug Investigation. 2026;46(9):1031-1036. doi:10.1007/s40261-026-01581-9
BibTeX
@article{ElSerafi2026,
author = {El-Serafi, Ibrahim and He, Rui and Zhao, Ying and Mattsson, Jonas and Hassan, Moustapha},
title = {Altered Busulphan Exposure Associated with Concomitant Omeprazole during Hematopoietic Stem Cell Transplantation Conditioning: A Two-Case Report},
journal = {Clinical Drug Investigation},
year = {2026},
volume = {46},
number = {9},
pages = {1031--1036},
doi = {10.1007/s40261-026-01581-9}
}
EUVIMED